Lexeo Therapeutics (LXEO) Insider Trading & Ownership $8.24 +0.05 (+0.55%) As of 03:58 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Lexeo Therapeutics (NASDAQ:LXEO) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage5.30%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$142.49K Get LXEO Insider Trade Alerts Want to know when executives and insiders are buying or selling Lexeo Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. LXEO Insider Buying and Selling by Quarter Lexeo Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/18/2025Eric AdlerInsiderSell608$4.67$2,839.36 8/18/2025Jose Manuel OteroInsiderSell2,848$4.67$13,300.16 8/18/2025Richard Nolan TownsendCEOSell2,735$4.67$12,772.45 8/18/2025Tai Sandi SeeInsiderSell382$4.67$1,783.94 5/16/2025Eric AdlerInsiderSell585$2.77$1,620.45 5/16/2025Richard Nolan TownsendCEOSell1,074$2.77$2,974.98 5/16/2025Tai Sandi SeeInsiderSell367$2.77$1,016.59 2/19/2025Richard Nolan TownsendCEOSell4,326$4.41$19,077.66 2/19/2025Tai Sandi SeeInsiderSell1,486$4.41$6,553.26 12/10/2024Richard Nolan TownsendCEOSell2,500$8.20$20,500.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 11/11/2024Richard Nolan TownsendCEOSell2,500$7.82$19,550.00 10/10/2024Richard Nolan TownsendCEOSell5,000$8.10$40,500.00 (Data available from 1/1/2013 forward) LXEO Insider Trading Activity - Frequently Asked Questions Who is on Lexeo Therapeutics' Insider Roster? The list of insiders at Lexeo Therapeutics includes Eric Adler, Fund Vi L.P. Omega, Jose Manuel Otero, Richard Nolan Townsend, and Tai Sandi See. Learn more on insiders at LXEO. What percentage of Lexeo Therapeutics stock is owned by insiders? 5.30% of Lexeo Therapeutics stock is owned by insiders. Learn more on LXEO's insider holdings. Which Lexeo Therapeutics insiders have been buying company stock? The following insider purchased LXEO shares in the last 24 months: Fund Vi L.P. Omega ($4,999,995.00). How much insider buying is happening at Lexeo Therapeutics? Insiders have purchased a total of 454,545 LXEO shares in the last 24 months for a total of $4,999,995.00 bought. Which Lexeo Therapeutics insiders have been selling company stock? The following insiders have sold LXEO shares in the last 24 months: Eric Adler ($4,459.81), Jose Manuel Otero ($13,300.16), Richard Nolan Townsend ($671,263.59), and Tai Sandi See ($9,353.79). How much insider selling is happening at Lexeo Therapeutics? Insiders have sold a total of 61,380 Lexeo Therapeutics shares in the last 24 months for a total of $698,377.35 sold. Lexeo Therapeutics Key ExecutivesMr. R. Nolan Townsend (Age 43)CEO & Director Compensation: $864.34kDr. Eric Adler M.D. (Age 50)Chief Medical Officer & Head of Research Compensation: $623.4kMs. Jenny R. Robertson (Age 49)Chief Business & Legal Officer Compensation: $617.9kDr. Ronald G. Crystal M.D.Co-Founder, Chief Scientific Advisor & Member of Scientific Advisory BoardDr. Paul B. McCormac Ph.D. (Age 54)Chief Technical Officer Compensation: $471.73kDr. Jordan Shin M.D.Ph.D., Senior Vice President of Clinical Development & Translational Science, CardiologyDr. Jordan S. Dubow M.D. (Age 45)Head of CNS Clinical Development Dr. Sandi See Tai M.D. (Age 53)Chief Development Officer Mr. Ryan McHenryVP & Corporate Controller More Insider Trading Tools from MarketBeat Related Companies Arcus Biosciences Insider Buying Stoke Therapeutics Insider Buying LENZ Therapeutics Insider Buying Syndax Pharmaceuticals Insider Buying Sionna Therapeutics Insider Buying Xeris Biopharma Insider Buying Taysha Gene Therapies Insider Buying Nuvation Bio Insider Buying Ardelyx Insider Buying Amphastar Pharmaceuticals Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Marvell Insiders Buy Shares—Should Investors Follow Suit?This Insider Just Made a Massive Bet on Transocean's ComebackInsider Sales Jump at Broadcom and CoreWeave: Red Flag Ahead?Oklo Insiders Sell! Oh No! This Is Why Investors Shouldn’t WorryTop Insider Buys and Sells From September: Buy, Sell, or Hold? This page (NASDAQ:LXEO) was last updated on 10/10/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredU.S. Government Sparking Crypto RallyAltcoin ETFs could surge prices (do this now) My "Crypto Bull Run Millionaire Blueprint" breaks down exactl...Crypto 101 Media | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredElon’s Out 🚫. Trump’s DOGE Payouts Keep Flowing (Up to $32K a Year)DOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredBig Oil Firm Stakes $1 Billion in Startup That Could Kill Big OilOn September 22, the unthinkable happened... One of the world's biggest oil producers poured $1 billion int...Stansberry Research | SponsoredToo busy for AI trading?Last week, Nvidia and AMD stock soared as export restrictions eased. Nvidia alone gained nearly 5% in a sin...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lexeo Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lexeo Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.